Onderneming Protalix BioTherapeutics, Inc.
Aandelen
PLX
US74365A3095
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,15 USD | -2,54% | 0,00% | -35,39% |
Vakgebied
Aantal werknemers: 208
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Recombinant Therapeutic Proteins
100,0
%
| 48 | 100,0 % | 38 | 100,0 % | -19,50% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Global
56,3
%
| 22 | 46,9 % | 22 | 56,3 % | -3,33% |
United States
26,5
%
| 12 | 26,0 % | 10 | 26,5 % | -18,08% |
Brazil
16,7
%
| 9 | 19,8 % | 6 | 16,7 % | -32,29% |
Italy
0,5
%
| 3 | 7,2 % | 0 | 0,5 % | -94,50% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 57 | 30-06-19 |
Eyal Rubin
DFI | Director of Finance/CFO | 48 | 22-07-19 |
Yael Hayon
CTO | Chief Tech/Sci/R&D Officer | 41 | 05-07-20 |
Yaron Naos
COO | Chief Operating Officer | 60 | 01-01-04 |
Gina Balderas
PRN | Corporate Officer/Principal | - | - |
Fellous Yael
HRO | Human Resources Officer | - | 01-08-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pol Boudes
BRD | Director/Board Member | 67 | 01-12-19 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 01-12-19 |
Aharon Schwartz
BRD | Director/Board Member | 80 | 01-11-14 |
Amos Bar Shalev
BRD | Director/Board Member | 71 | 01-07-08 |
Eliot Forster
CHM | Chairman | 58 | 14-09-23 |
Shmuel Ben Zvi
BRD | Director/Board Member | 64 | 30-06-22 |
Dror Bashan
CEO | Chief Executive Officer | 57 | 30-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 73 052 124 | 65 915 784 ( 90,23 %) | 0 | 90,23 % |
Bedrijfsgegevens
Protalix Biotherapeutics, Inc.
2 University Plaza Suite 100
07601, Hackensack
+972 4 902 8100
http://www.protalix.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,39% | 86,2 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |